Showing results (251-260 of 342) with videos related to

Sort By:
Pageof 35
Chest|July 12, 2021
Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary FibrosisHironao Hozumi, Kensuke Kataoka, Yasuhiro Kondoh, et al.
Respirology (Carlton, Vic.)|February 26, 2019
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysisHironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, et al.
Respiratory Medicine|October 4, 2016
Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthmaKazutaka Mori, Tomoyuki Fujisawa, Naoki Inui, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 6, 2024
3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitisShusuke Yazawa, Yuzo Suzuki, Yuko Tanaka, et al.
Scientific Reports|September 18, 2021
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosisYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.
Scientific Reports|July 30, 2021
Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertensionNoriyuki Enomoto, Seiichiro Suzuki, Hironao Hozumi, et al.
Respiratory Research|January 10, 2024
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapyYoshihiro Kitahara, Yusuke Inoue, Hideki Yasui, et al.
Therapeutic Advances in Respiratory Disease|September 15, 2020
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosisYuya Aono, Yutaro Nakamura, Masato Kono, et al.
Respirology (Carlton, Vic.)|May 23, 2023
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosisYasutaka Mochizuka, Yuzo Suzuki, Masato Kono, et al.
Scientific Reports|October 23, 2013
SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancersShun Matsuura, Tomoaki Kahyo, Kazuya Shinmura, et al.
Pageof 35